GAS5 is a known competing endogenous RNA for miR-137, which targets YBX1 in thoracic cancers (see above in this section) (Chen et al., 2018), so it is possible that this may contribute toward YBX1 translational upregulation. The gene discussed is YBX1; the disease is thoracic cancer.